Activase 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FXK7G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,311
Award facts
- Contract value 100% obligated
- $12,310.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $12,310.91 by the Defense Logistics Agency (DLA) for the supply of Activase 100 mg vials, a thrombolytic medication used in emergency medical treatment. The contract is non-competitive and carries a firm fixed price structure, with an ultimate completion date of December 18, 2025. The award was issued on December 17, 2025, and the place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supports military and veteran healthcare systems through the DLA's Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains and has demonstrated capability to fulfill federal procurement requirements through both competitive and non-competitive awards. This particular delivery order for Activase supports the DLA's mission to supply essential medications to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The firm fixed pricing and rapid turnaround reflect the standardized procurement processes typical of delivery orders issued under established pharmaceutical prime vendor contracts.
Quick answers
Who was awarded contract SPE2DR26FXK7G?
SPE2DR26FXK7G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FXK7G worth?
The government has obligated $12,311 on SPE2DR26FXK7G.
Is contract SPE2DR26FXK7G an order under another contract?
Yes. SPE2DR26FXK7G is a delivery order under SPE2DR25D6037, an indefinite delivery contract.
Was contract SPE2DR26FXK7G competed?
The extent of competition for SPE2DR26FXK7G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award